Try our Advanced Search for more refined results
Novartis Pharmaceuticals Corporation et al v. Alvogen Pine Brook Inc. et al
Case Number:
1:13-cv-00052
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
June 24, 2014
Del. Court Sides With Alvogen In Novartis Patent Row
A Delaware federal judge on Tuesday tossed out a lawsuit Novartis AG brought against Alvogen Group Inc. over a generic version of the Exelon dementia treatment patch, signing off on the argument that the drug lacked a key ingredient and thus did not infringe Novartis' patents.
-
January 07, 2013
Novartis Sues Alvogen To Block Generic Dementia Patch
Novartis AG slapped generic-drug maker Alvogen Group Inc. with a lawsuit in Delaware on Friday, accusing Alvogen of infringing two patents by seeking U.S. regulatory approval to make and sell generic versions of the Exelon patch, a dementia treatment.